blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1096254

EP1096254 - Capillary hematocrit separation structure and method [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  10.02.2006
Database last updated on 11.09.2024
Most recent event   Tooltip27.07.2007Lapse of the patent in a contracting state
New state(s): IT
published on 29.08.2007  [2007/35]
Applicant(s)For all designated states
Roche Diagnostics Corporation
9115 Hague Road
Indianapolis, IN 46250 / US
[2001/18]
Inventor(s)01 / Bhullar, Raghbir S.
6130 Chadsworth Way
Indianapolis, IN 46236 / US
02 / Wilsey, Christopher D.
516 Oak Drive
Carmel, IN 46032 / US
03 / Shelton, Jeffrey N.
11305 Hickory Woods Drive
Fishers, IN 46038 / US
 [2001/18]
Representative(s)Jung, Michael, et al
Roche Diagnostics GmbH Patentabteilung Sandhofer Strasse 116
68305 Mannheim / DE
[N/P]
Former [2001/18]Jung, Michael, Dr., et al
Roche Diagnostics GmbH Patentabteilung
68298 Mannheim / DE
Application number, filing date00123020.024.10.2000
[2001/18]
Priority number, dateUS1999042869128.10.1999         Original published format: US 428691
[2001/18]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP1096254
Date:02.05.2001
Language:EN
[2001/18]
Type: A3 Search report 
No.:EP1096254
Date:13.06.2001
[2001/24]
Type: B1 Patent specification 
No.:EP1096254
Date:06.04.2005
Language:EN
[2005/14]
Search report(s)(Supplementary) European search report - dispatched on:EP04.05.2001
ClassificationIPC:G01N33/49, B01L3/00
[2001/18]
CPC:
G01N33/491 (EP,US); B01L3/502746 (EP,US); B01L3/502753 (EP,US);
B01L2300/0681 (EP,US); B01L2300/0825 (EP,US); B01L2400/0406 (EP,US);
B01L2400/086 (EP,US); Y10T436/25125 (EP,US); Y10T436/25375 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2001/18]
TitleGerman:Struktur und Verfahren zur kapillaren Hämatokritabtrennung[2001/18]
English:Capillary hematocrit separation structure and method[2001/18]
French:Structure et méthode pour la séparation capillaire d'hématocrite[2001/18]
Examination procedure24.10.2000Examination requested  [2001/18]
19.04.2004Despatch of a communication from the examining division (Time limit: M04)
13.08.2004Reply to a communication from the examining division
04.10.2004Communication of intention to grant the patent
04.02.2005Fee for grant paid
04.02.2005Fee for publishing/printing paid
Opposition(s)10.01.2006No opposition filed within time limit [2006/13]
Fees paidRenewal fee
15.10.2002Renewal fee patent year 03
14.10.2003Renewal fee patent year 04
14.10.2004Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT06.04.2005
BE06.04.2005
CH06.04.2005
FI06.04.2005
IT06.04.2005
LI06.04.2005
NL06.04.2005
DK06.07.2005
GR06.07.2005
SE06.07.2005
ES17.07.2005
PT08.09.2005
CY24.10.2005
[2007/35]
Former [2007/20]AT06.04.2005
BE06.04.2005
CH06.04.2005
FI06.04.2005
LI06.04.2005
NL06.04.2005
DK06.07.2005
GR06.07.2005
SE06.07.2005
ES17.07.2005
PT08.09.2005
CY24.10.2005
Former [2006/14]AT06.04.2005
BE06.04.2005
CH06.04.2005
FI06.04.2005
LI06.04.2005
NL06.04.2005
DK06.07.2005
GR06.07.2005
SE06.07.2005
ES17.07.2005
PT08.09.2005
Former [2006/13]AT06.04.2005
BE06.04.2005
FI06.04.2005
DK06.07.2005
SE06.07.2005
Former [2005/52]FI06.04.2005
SE06.07.2005
Former [2005/50]SE06.07.2005
Documents cited:Search[A]US3693438  (YAMASAKI HIROO, et al) [A] 4,5,13,14* the whole document *;
 [A]GB1589690  (ROSEMOUNT INC) [A] 1,4-6,13-15 * the whole document *;
 [DA]US4756884  (HILLMAN ROBERT S [US], et al) [DA] 1,7,9,10,12,16,18,19,21 * column 1, line 13 - column 7, line 56 * * column 28, line 21 - line 46 *;
 [DA]US5135719  (HILLMAN ROBERT S [US], et al) [DA] 1,12,21 * column 1, line 59 - column 7, line 38 *;
 [A]EP0596104  (BIOSITE DIAGNOSTICS INC [US]) [A] 1,12,21,22 * column 1, line 24 - column 5, line 60 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.